Propanc Biopharma, Inc.
PPCB
$1.95
-$0.20-9.30%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
9/2/2025
-
GuruFocus
9/2/2025
-
GuruFocus
9/2/2025
-
The Fly
9/2/2025
-
GuruFocus
9/2/2025
-
Globe Newswire
8/25/2025
-
GuruFocus
8/25/2025
-
GuruFocus
8/25/2025
-
The Fly
8/25/2025
-
Globe Newswire
8/19/2025
-
Globe Newswire
8/15/2025
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, July 28, 2025
Period Date
Monday, March 31, 2025
Next Filing
End of September (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
61 3 9882 0780
Address
302, 6 Butler Street
Camberwell, VIC 3124
Camberwell, VIC 3124
Country
Year Founded
Business Description
Sector
Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in...
more